companydata.dkcompanydata.dk

PHARMA-TECH A/S: Financial statements 2014

CVR: 32940897

Source: annual report 2014, Danish Business Authority

01/01/201431/12/2014

PHARMA-TECH A/S (CVR 32940897) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 11,197,097 and a net result of DKK 2,863,690 compared with DKK 1,735,104 the year before. That is an increase of 9.8% compared with the year before. Equity in the 2014 report amounted to DKK 7,225,238. The solvency ratio was 58.7%.

Gross Profit
DKK 11,197,097
Profit/Loss
DKK 2,863,690
Equity
DKK 7,225,238
Total Assets
DKK 12,310,468

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-11.2 mio.2.9 mio.7.2 mio.-
2013-10.2 mio.1.7 mio.4.4 mio.9
2012-5.4 mio.1.5 mio.2.6 mio.7

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

PHARMA-TECH A/S: The 2013 annual report is outApr 30, 2014

PHARMA-TECH A/S has published its annual report for 2013. Gross profit came to DKK 10,199,853, and the net result was DKK 1,735,104.

PHARMA-TECH A/S appoints new auditorApr 24, 2014

As of April 24, 2014, A/S PSE 17 NR. 1056 has been appointed auditor of PHARMA-TECH A/S.

Auditor steps down at PHARMA-TECH A/SApr 24, 2014

As of April 24, 2014, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of PHARMA-TECH A/S.

About PHARMA-TECH A/S

PHARMA-TECH A/S is a Danish company of the type Aktieselskab based in Randers SV, founded in 2010. The company is registered under the industry Fremstilling af plastemballage. The management consists of Morten Hart Johansen. The board consists of Claus Wædeled (chair), Morten Hart Johansen and Rikke Winther. The company is owned by JoWin Holding ApS. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. Equity in the 2025 report amounted to DKK 24,456,581.

Source: annual report 2025, Danish Business Authority